Literature DB >> 25164840

Ipilimumab-induced hypophysitis: early Australian experience.

Sunita M C De Sousa1, Georgina V Long2, Katherine T Tonks3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25164840     DOI： 10.5694/mja14.00803

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.

Authors:  Sunita M C De Sousa; Nisa Sheriff; Chau H Tran; Alexander M Menzies; Venessa H M Tsang; Georgina V Long; Katherine T T Tonks
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 2.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

Review 3.  Immunotherapy-induced endocrinopathies: assessment, management and monitoring.

Authors:  Edson Nogueira; Tom Newsom-Davis; Daniel L Morganstein
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-25       Impact factor: 3.565

Review 4.  Endocrine toxicity of cancer immunotherapy: clinical challenges.

Authors:  Bliss Anderson; Daniel L Morganstein
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.